Proteins and Peptides

21 May 2008 Paion's Anticoagulant Solulin Achieves Proof Of Concept For Mode of Action in Phase I
20 May 2008 Halozyme Therapeutics Presents Pre-Clinical Studies on Dermal Remodeling With HTI-501, a Lysosomal Proteinase
20 May 2008 BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKUBioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
20 May 2008 Palatin Technologies initiates phase 2 hypertension clinical study with PL-3394
19 May 2008 Ipsen and Medicis Announce Acceptance of Reloxin BLA in Aesthetics by FDA
19 May 2008 Sangart, Inc. Completes Enrollment In Second Phase III Study of Hemospan, A Novel Oxygen Transport Agent
19 May 2008 New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) For Injection Based Therapies In Patients With Newly Diagnosed Multiple Myeloma
19 May 2008 Gloucester Pharmaceuticals Announces Positive Results from Phase 2b Registration Trial of Romidepsin in Refractory CTCL
16 May 2008 The GI Company Reports Significant Reduction in Occurrence of Oral Mucositis in Phase II Study; Abstract Posted Online at
16 May 2008 ZymoGenetics Announces Publication of Five IL-21 ASCO Abstracts
15 May 2008 Ambrilia Reports Positive Final Phase III Results for its Octreotide Formulation C2L
15 May 2008 Protox Doses First Patient In Phase 2 BPH Clinical Trial
14 May 2008 Æterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
14 May 2008 Platin Technologies announces new strategis objectives and reports third quater 2008 financial results
12 May 2008 FDA Approves New Formulation of Coagulation Therapy
12 May 2008 Theratechnologies and PDC Biotech GmbH sign license agreement for family of peptides for Preterm Labour and Primary Dysmenorrhea programs
12 May 2008 Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
12 May 2008 Affymax and Takeda Announce Long-Term Hematide Safety and Effectiveness Data from Phase 2 Clinical Trials in Chronic Kidney Disease Patients with Anemia
12 May 2008 Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy
08 May 2008 OrthoLogic Announces Positive Safety Data for Initial AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring
08 May 2008 LFB Biotechnologies and GTC Biotherapeutics to collaborate on rhAAT program
07 May 2008 Microbix to spin off Urokinase into newly formed Klarogen Biotherapeutics; Klarogen to acquire all remaining Urokinase inventory, sales and marketing infrastructure and NDA from ImaRx upon completion of financing
06 May 2008 Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
06 May 2008 Omigard(TM) Phase III Pivotal Registration Study Enrollment Completed
06 May 2008 Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up